This article is protected by copyright. All rights reserved.
INTRODUCTION
Endocannabinoids are a group of polyunsaturated fatty acid-based compounds that mimic most of the effects tetrahydrocannabinol, the active ingredient of the marijuana plant Cannabis sativa. Narachidonoyl ethanolamide (AEA) or Anandamide and 2-arachidonylglycerol are the most widely studied endogenous cannabinoids (Di Marzo et al., 2005; Hanus and Mechoulam, 2010) . In recent years, extensive research focusing on the biological actions of these compounds indicated that endocannabinoids have important regulatory roles in several physiological and pathological conditions (Pacher et al., 2006; Di Marzo et al., 2005; Pertwee et al., 2010) . It has been shown that endocannabinoid system consists of at least the endocannabinoid receptors (such as CB1 and CB2 cannabinoid receptors), the enzymes regulating the synthesis (such as phospholipase-D, and monoacylglycerol lipase), and the degradation (such as fatty-acid amide hydrolase and lipases) processes, and the proteins involved in their transport across the biological membranes (Di Marzo et al., 2005; Pertwee et al., 2010) . CB 1 receptors are located in the brain and several peripheral tissues including the heart and the vasculature (Pertwee et al., 2010) . The CB 2 receptors, on the other hand, are expressed primarily in the immune system but recently their presence in the brain, myocardium, and smooth muscle cells have also been demonstrated (Pertwee et al., 2010) .
Recent studies suggest that endocannabinoids have important modulatory roles on the function of cardiovascular system under various pathological conditions, such as hypertension, myocardial infarction and heart failure [for recent reviews, (Batkai and Pacher, 2009; Montecucco and Di Marzo, 2012) ]. AEA, the most studied endocannabinoid, has complex set of actions on cardiac functions.
Experiments with AEA performed in isolated Langendorff rat hearts and in isolated, electrically stimulated human atrial appendages (Ford et al., 2002; Bonz et al., 2003) have revealed a negative Accepted Article inotropic effect which may underlie its ability to decrease cardiac output as observed in studies performed in vivo (Wagner et al., 2001) . Moreover, AEA and other cannabinoids have been reported to have antiarrhythmic effects in in vivo animal models (Krylatov et al., 2002; Ugdyzhekova et al., 2001 ).
In a recent study a weak protective effect of endocannabinoids during the late stages of ischemia has been suggested to be mediated by CB1 receptors (Andrag and Curtis, 2013) . Another study reported that AEA potently inhibits the function of L-type Ca 2+ channels by activating CB1 receptors in rat cardiomyocytes (Li et al., 2009) . However, electrophysiological mechanisms underlying these cardiac actions of AEA remain largely unknown. We hypothesized that some of the negative inotropic and antiarrhythmic actions of AEA can be mediated by the modulation of voltage-gated inward Na + and Ca 2+ channels. Thus, in the present study, using whole-cell patch clamp and radioligand binding methods, we investigated the actions of AEA on these major inward currents underlying the shape of the action potential in acutely dissociated rat ventricular myocytes. Health Sciences, UAE University. All studies involving animals are reported in accordance with the ARRIVE guidelines for reporting experiments involving animals McGrath et al., 2010) .The original stocks of Wistar rats were purchased from Harlan Laboratories (Oxon, England). Animals were bred at our own Animal Facility from the original stock. The animals were housed in polypropylene cages (43 x 22.5 x 20.5 cm; six rats/cage) in climate and access controlled rooms (22-24 °C; 50 % humidity). The day/ night cycle was 12 h/12h. Food and water were provided ad libitum. The food was standard maintenance diet for rats purchased from Emirates Feed Factory (Abu Dhabi, UAE). Ventricular myocytes were isolated from adult male Wistar rats (264 ± 19 g) according to previously described technique (Howarth et al., 2002) . Briefly, the animals were euthanized using a guillotine and hearts were removed rapidly and mounted for retrograde perfusion according to the Langendorff method. Hearts were perfused at a constant flow of 8 ml g heart-1 min-1 and at 36-37 ˚C with a solution containing (mM): 130 NaCl, 5. min at 37°C in the cell-culture incubator. TTX was added to prevent depolarization induced by Na + influx induced by the toxins (Sheldon et al., 1986) . Various concentrations of metAEA dissolved in ethanol were added in volumes of 3-5 µl to the incubation buffer (The same volumes of ethanol were added to the control samples). These volumes of ethanol had no effect on the [ 3 H]BTX-B binding).
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Methods
Assays were done in parallel with tubes containing 0.4 mM aconitine to define nonspecific binding. At the end of the 60-min incubation period, 150 µl of the reaction mixture (cell suspension) from each sample were filtered through a Whatman GF/C 25-mm fiber-glass filter under vacuum. Sea anemone toxin and TTX were obtained from Sigma-Aldrich. metAEA was dissolved weekly in ethanol at the concentration of 10 mM and stored at -20°C.
Preparation of cardiac muscle membranes: Cardiac membranes were prepared from the heart of adult male Wistar rats by some modifications of previously described methods (Dunn, 1989; Oz et al., 2000) . Briefly, rat heart was minced with scissors and washed two times with ice-cold binding buffer to remove extraneous blood. The tissue (one heart in a 50-ml) was placed in plastic centrifuge tube containing 10 ml ice-cold buffer (50 mM Tris⋅Cl, pH 7.2) and homogenized on ice by two 5-sec bursts in a Polytron homogenizer at setting 5. The solution was decanted to a motor-driven 10-ml glass-Teflon homogenizer and homogenized on ice by 10 passes at setting 8. The homogenate was filtered through four layers of cheesecloth (to remove tissue debris) into a clear 50-ml centrifuge tube and centrifuged for 45 min at 45,000 × g, 4°C. The pellet was suspended in 5 ml ice-cold binding buffer for each rabbit heart by homogenizing the pellet five times on ice with a motor-driven 10-ml glass-Teflon homogenizer at setting 5. Membrane protein concentration was determined using the Bradford method using BSA as a standard. The membranes were diluted in binding buffer to 1 mg protein/ml and store in 5-ml aliquots at -70°C. (Specific activity 58.6 Ci /mmol, New England Nuclear, Chadds Ford, PA, USA) were conducted similar to our earlier studies (Oz et al., 2000) . Briefly, aliquots of membranes (0.1 mg) were added to 
Radioligand
Data Analysis:
The results of the experiments were expressed as mean ± standard error of the mean (S.E.M.). Statistical analysis was performed using the paired t-test (within the same cell analysis).
Statistical significance among groups was determined using one way ANOVA followed by Benferonni
Post-hoc analysis. Statistical analysis of the data was performed using Origin 7.0 software (OriginLab Corp., Northampton, MA) and IBM SPSS statistics version 20. On all graphs (*) denotes statistical significance with P<0.05, between specified values, or if not specified to the respective control.
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RESULTS
The passive properties of the ventricular cells from controls were not significantly different from those of the AEA treated cells. Resting membrane potentials (mean ± SEM) were -76.2 ± 1.3 and -78.3 ± 1.5 mV in control (n=38) and AEA treated (n=53) myocytes, respectively. The mean cell capacitance in the control group was 117.2 ± 14.7 pF, whereas in the AEA treated cells was 108. 
Effects of AEA on voltage-dependent Na + channels:
Previous studies have indicated that AEA has significant antiarrhythmic effects suggesting that this compound may affect voltage activated inward Na + (I Na ) and Ca 2+ (I L,Ca ) currents of ventricular myocytes. To verify these possibilities, we have conducted a series of experiments under conditions that enable reliable isolation of either I Na or I Ca in voltage-clamp mode. In the first set of experiments, I Na was typically elicited by pulses from -80 mV to -20 mV for 50 ms. Figure 1A shows recordings of I Na in ventricular myocytes before, during and after application of 10 µM AEA. The effect of AEA was detectable at 2-3 min and reached a steady-state level within 10-15 min (Fig. 1B) . The recovery was
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partial during the experiments lasting up to 25 to 30 min (Fig. 1B) . In our studies, AEA was dissolved in ethanol, and therefore we have tested the effect of ethanol as a vehicle. In agreement with earlier studies (Danziger et al., 1991; Bebarova et al., 2010) , our results indicated that maximal amplitudes of I Na were altered after 10 min vehicle application in experiments lasting up to 20 to 25 min. Due to the effect of vehicle, we have tested each concentration of AEA and vehicle separately and plotted the concentration response curve after the subtraction of vehicle effect (Supplement Figure 1) . The effect of increasing AEA and corresponding ethanol concentrations and corrected concentration-response curve were presented in supplement Figure 1 . In order to exclude the possibility of the involvement of degradation products of AEA in the inhibition of Na + current, the effect of 10 µM metAEA was tested.
metAEA caused a significant inhibition of Na + currents (36 ± 4 % inhibition of controls; n=5; paired ttest).
With 40 mМ Na + outside and Cs + as the major intracellular cation, inward I Na in response to incremental step depolarizations (V m , 10 mV increment) applied from a holding potential V h = -80 mV started to activate at V m = -50 mV, and reached maximal amplitude at V m = -30 mV. At more positive potentials the inward current decreased reversing its direction at an apparent reversal potential (V rev ) of around +60 mV. Traces of I Na in the absence and presence of 10 µM AEA were presented in Figure 1C .
AEA inhibited I Na without causing significant changes in the I-V relationship. The current-voltage (I-V) relationship for I Na was illustrated in Figure 1D . AEA inhibited I Na without changing the threshold, peak and reversal potentials.
Steady-state activation (SSA) curves of I Na before and after AEA application were derived by fitting the respective I-V relationships with the product of Boltzmann and Goldman-Hodgkin-Katz (GHK) equations of which the first one describes voltage-dependence of SSA, and the second one the current through open channels. This allowed us to determine if AEA influences the parameters of I Na
SSA-the voltage of half-maximal activation (V 1/2 ) and slope factor (k). In controls, V 1/2 and k values were -45.2 mV and 7.1 mV, respectively. In the presence of 10 µM AEA, V 1/2 and k values were -42.3 mV, and 7.5 mV ( Fig. 2A ). There were no statistically significant differences between controls and in the presence of AEA (ANOVA, n=8-10; P>0.05).
In order to determine if AEA influences the properties of voltage gated sodium channels (VGSCs) inactivation, we compared steady-state inactivation (SSI) dependencies of I Na in the absence and presence of AEA. SSI-curves were acquired using a standard voltage protocol consisting of prolonged (400 ms) conditioning pre-pulse to various V m in the range of -100 mV to +70 mV which was immediately followed by the constant I Na -activating test pulse to V m = -20 mV. SSI-dependency was plotted as normalized amplitude of I Na at V m = -20 mV against the value of conditioning V m (normalization was performed to the amplitude of I Na at conditioning V m = -100 mV). The fit of the obtained data points using the Boltzmann equation ( between -50 mV and +20 mV (Fig. 2C ).
The rat heart has been shown to expresses CB1 and CB2 receptors (Bouchard et al., 2003) .
Therefore it was likely that the effect of AEA is mediated by the activation of these receptors. For this purpose we have chosen two antagonists (AM251 and AM630) for their relative selectivity for CB1 versus CB2 receptor (Lan et al., 1999; Ross et al., 1999) defined in accordance with the nomenclature Accepted Article of the Guide to Receptors and Channels (Alexander et al., 2011) . In the presence of 0.3 µM AM251, a CB1 antagonist with K i of 7.5 nM (Lan et al., 1999) and 0.3 µM AM630, a CB2 antagonist with K i of 32.1 nM (Ross et al., 1999) , AEA (10 µM) inhibition of I Na remained unaltered (n=6-8, data not shown). Since the known cannabinoid receptors CB1 and CB2 [for a review (Pertwee et al., 2010) ] are coupled to pertussis toxin (PTX) sensitive G i/o type G-proteins, we have tested whether the inhibitory effect of AEA on I Na can be modulated by PTX pretreatments. Our results show that the extent of the inhibitory effect of AEA on the maximal amplitudes of I Na was not affected by PTX pretreatment (Fig.   2D ). There were no statistically significant difference in the % inhibition by AEA in control and PTXtreated groups (n=6-8; ANOVA; P>0.05). In positive control experiments, PTX, as it has been reported earlier (Zhang et al., 2005) (Sheldon et al., 1986; Kang and Leaf, 1996) and neuronal structures (Postma and Catterall, 1984) has been well characterized in earlier investigations. In this study, due to long incubation times (up to 60 min), we have tested the effect of methanandamide (metAEA), a nonhydrolysable AEA analogue (Abadji et al., 1994) (Fig. 3A) . We have also investigated the effect of CB receptor antagonists AM251 (1µM) and AM630 (1µM) on the specific binding of 10
Results presented in Figure 3D indicate that the effect of metAEA (10 µM) on the We have also investigated the effect of AEA (1 µM) on the L-type Ca 2+ currents (I L,Ca ). Figure   4A shows a typical record of I L,Ca elicited by applying a single 300 ms voltage pulse to +10 mV from a holding potential of -50 mV in rat ventricular myocyte before and after 10 min superfusion with 1µM
AEA. Time course of the effect of AEA on the density of I L,Ca was presented in Figure 4B . Current relatively depolarized V h of -50 mV, which produced steady-state I Na inactivation (Voitychuk et al., 2012) . As evident from original recordings and I-V relationships (Fig. 4C, D) , I L,Ca had much slower kinetics in response to step depolarization and activated at more positive potentials than I Na : it started to appear at Vm = -30 mV, reached maximum at around V m = +10 mV, and decreased at higher voltages approaching zero at about V m = +60 mV (Fig.4D) .
AEA also produced a depolarizing shift of I L,Ca SSA by 12.6 mV (i.e., from control value V 1/2 = -9.4 ± 0.3 mV to V 1/2 = +3.2 ± 0.2 mV in the presence of AEA) and hyperpolarizing shift of I L,Ca SSI by 4.3 mV (i.e., from control value V 1/2 = -18.9 ± 0.1 mV to V 1/2 = -23.2 ± 0.1 mV in the presence of AEA) with little influence on the slopes of respective dependencies (k=7. 2 ± 0.4 mV and k=-5.3 ± 0.3 mV for the control activation and inactivation, respectively, vs. k=6.9 ± 0.3 mV and k=-5.1±0.2 mV for the AEA-modified activation and inactivation, respectively), which altogether resulted in the notable reduction of I L,Ca "window current" responsible for the stationary Ca 2+ entry in the range of membrane potentials from -40 mV to +10 mV (Fig. 5A, B) . Thus, the mechanism of AEA action on cardiac L-type voltage gated calcium channel (VGCC) most likely involves influence on channel gating that reduces
Accepted Article "window current" as well as partial blockade of the ion-conducting pathway that decreases current amplitude. In time matching controls measured after 10 min of ethanol application, activation and inactivation parameters was not significantly different compared to time-matched controls (without ethanol application after 10 to 15 min of patching time). V 1/2 values for activation and inactivation were -10.3 ± 0.4 mV and -20.6 ± 0.7 for controls, and -9.7 ± 0.6 mV and -19.6 ± 0.8 in the presence of 0.007% (1.5 mM) ethanol, respectively (n=7-9; ANOVA, P>0.05).
In line with earlier reports (Soldatov et al., 1998) In earlier electrophysiological studies, sidedness of AEA actions on various ion channels has been reported (Oz, 2006) . For this reason, we have tested the effect of intracellular application of AEA by including AEA (1 µM) inside the patch electrode (Fig. 5D ). The extent of AEA inhibition (compared after 15 min of AEA exposure) was not significantly different between intracellular and extracellular AEA applications (ANOVA; n=11-14; P>0.05). We have also conducted experiments with URB597, a potent inhibitor of FAAH which is the enzyme that hydrolyzes AEA (incubation of 1 µM URB597 for 45 min at 37 °C versus controls incubated with 0.007 % ethanol alone for 45 min at 37 °C). Our results indicate that the effect of 1 µM AEA on L-type Ca 2+ currents remained unaltered in URB597-incubated cells. The extent of AEA inhibition was in the presence and absence of URB597 treatment was 35 ± 4 % and 32 ± 3 %, respectively (n=5-7; ANOVA, P>0.05).
In In line with earlier studies (Soldatov et al., 1998) , inactivation of I Ba fit to mono-exponential decay function ( Fig. 6A ) with significant voltage-dependency. In the presence of AEA, inactivation time constant ( Fig. 6A and 6B) , and the maximal amplitudes of I Ba were significantly inhibited compared to control values (paired t-test; n=7; P<0.05).
We have also investigated whether the inhibitory effects of AEA on L-type VGCCs are mediated by the activation of cannabinoid receptors. Since the known cannabinoid receptors CB1 and CB2 [for a review (Pertwee et al., 2010) ] are coupled to pertussis toxin (PTX) sensitive G i/o type Gproteins, we have tested whether the inhibitory effect of AEA on L-type VGCCs can be modulated by PTX pretreatments. Our results show that the inhibitory effect of AEA on the maximal amplitudes of I L,Ca was not affected by PTX pretreatment (Fig. 6C) . We have conducted further experiments in which 1 mM GTP was included in the pipette solution. In the presence of GTP, AEA (10 min bath application) continued to inhibit L-type Ca 2+ currents to 62 ± 4 % of controls (n=6). Furthermore, in the presence of 0.3 µM AM251, a CB1 antagonist with K i of 7.5 nM (Lan et al., 1999) and 0.3 µM AM630, a CB2 antagonist with K i of 32.1 nM (Ross et al., 1999) , AEA (1µM) inhibition of I L,Ca remained unaltered (Fig. 6D ). There were no statistically significant difference in the % inhibition by AEA among AEA, AEA+AM251, and AEA+AM630-treated groups (n=6-9; ANOVA; P>0.05).
Application of AM251 or AM630 alone did not have a significant effect on the amplitudes of I L,Ca (Fig .   6D ) (n=8; Paired t-test; P>0.05).
Effect of metAEA on [ 3 H]Isradipine binding:
In cardiac tissue, AEA is hydrolyzed to arachidonic acid (AA), and AA is known to inhibit the function of cardiac L-type Ca 2+ channels and cause negative inotropic actions (Li et al., 2009) ; for a review of earlier studies, (Oz, 2006) . Therefore it was possible that AA, rather than AEA, interacts with L-type Ca 2+ channels. For this reason, we tested the effect of metAEA, the metabolically stable chiral analogue of AEA which is resistant to hydrolytic inactivation by fatty acid amide hydrolase (Abadji et al., 1994) 
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DISCUSSION:
The results of this study indicate for the first time that previously reported actions of AEA on cardiac muscle contractility (negative inotropic effect) and the action potential (AP) configuration involves direct inhibition of voltage-dependent Na + and Ca 2+ channels in ventricular myocytes. Actions of endocannabinoids on cardiovascular system influence multiple organ systems and involve complex set of cellular and molecular mechanisms (Malinowska et al., 2012; Randall et al., 2004) . In addition to cannabinoid receptor-mediated actions, several other factors such as the activation of autonomic reflexes, the presence of endothelial cells and fatty-acid based metabolic products have been reported to contribute to the complexity of endocannabinoid actions on the heart. On the other hand, acutely dissociated ventricular myocytes have several advantages over in-vivo and traditional in-vitro conditions, since it excludes the influences of reflex pathways, autonomic nerve endings, neurotransmitter uptake system, gap-junction connections, and coronary perfusion status.
In our experiments, AEA caused a significant reduction in the maximal amplitudes of both Na + and Ca 2+ currents. Inhibitory effect of AEA, on VGSC, which is the major inward current during the upstroke (phase 0) of the AP is in agreement with our recently published current-clamp studies (Al Kury et al., 2014) indicating that AEA decreases the amplitude and initial rate of rise of the AP in ventricular myocytes. The results suggest that the effect of AEA on VGSC is not mediated by CB1 or CB2 cannabinoid receptors. Furthermore, radioligand binding experiments indicate that AEA can interact directly with VGSC in ventricular myocytes. In cardiac muscles, VGSCs are almost exclusively represented by their TTX-resistant Nav1.5 isoform (gene SCN5A; (Catterall et al., 2005a) ).
Therefore, the changes in the biophysical properties of I Na by AEA, namely induction of the hyperpolarizing shift in the voltage-dependence of its steady-state inactivation (SSI) can be attributed to their effects on Nav1.5 channel gating.
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A hyperpolarizing shift of the SSI indicates that a higher proportion of VGSCs would be inactivated at resting membrane potential and therefore substantially fewer channels would be available for activation, resulting in decreased amplitude and rate of rise during the upstroke of the AP. (Sheldon et al., 1994) . Therefore it is likely that AEA synthesized during the cell stress can bind to Nav1.5 channel and modulate the actions of local anesthetics and class I antiarrhythmics with Nav1.5 channel. Although this, to our knowledge, is the first demonstration of the direct inhibitory action of AEA on a muscle type voltage-dependent Na + channel, in several earlier investigations, AEA, at similar or higher concentrations, has been shown to inhibit directly the function of voltage-gated Na + channels in neuronal structures (Kim et al., 2005; Duan et al., 2008; Theile and Cummins, 2011; Nicholson et al., 2003) . In agreement with our findings, both AEA (Theile and Cummins, 2011) and its metabolic product arachidonic acid (Bendahhou et al., 1997) have been shown to increase inactivation of Na + channels. Inhibition of VGSCs would slow the conduction of depolarization in the heart. However, it is unlikely that the slowed conduction due to Na + channel inhibition alone would result in widening of QT interval observed in rat hearts (Farkas and Curtis, 2003) .
In addition to I Na , AEA caused a significant inhibition of cardiac I L,Ca , which is mediated by Cav1.2 (gene CACNA1C) isoform of L-type VGCCs (Catterall et al., 2005b) . This current contributes to the plateau of the cardiac AP (phase 2), therefore, its suppression causes both the decrease of the amplitude of the plateau and the shortening of the AP duration. In earlier studies, AEA has been shown to decrease the amplitude of the plateau and cause shortening of the AP duration [ (Li et al., 2009; Al Kury et al., 2014] . Our results show that AEA affects activation and inactivation gating of cardiac L- Mechanism of the inhibitory effect of AEA does not seem to involve Ca 2+ -induced inactivation process, since Ba 2+ currents through L-type VGCCs were effectively inhibited by AEA. In addition, AEA was equally effective upon intracellular or extracellular application suggesting that there is no sidedness for AEA actions on L-type VGCCs. Considering highly lipophilic nature of AEA, it is not surprising that AEA can access its binding site from both extra and intracellular sites effectively. The results of radioligand binding and electrophysiological studies indicated that AEA directly interacts with and inhibits the function of L-type Ca 2+ channels. Although, to our knowledge, this is the first Accepted Article demonstration of the direct effects of AEA on the L-type VGCC in cardiac muscle, similar results demonstrating the effects AEA on skeletal muscle L-type VGCCs have also been described in biochemical studies (Oz et al., 2000; Oz et al., 2004) . In our earlier studies in rabbit skeletal muscle, we have demonstrated that AEA inhibits the specific binding of [ 3 H]Isradipine to skeletal T-tubule membranes and directly inhibits the functions of skeletal muscle L-type Ca 2+ channels (Oz et al., 2000; Oz et al., 2004) in a manner that is independent of known cannabinoid receptors. In fact, earlier studies searching for endogenous modulators of L-type Ca 2+ channels have also identified AEA as a ligand for L-type Ca 2+ channels (Johnson et al., 1993) . Later investigations indicated that effects of AEA are not limited to L-type VGCCs in muscles, and other types of Ca 2+ currents in neuronal structures are also inhibited directly by endocannabinoids such as AEA [for a recent review, (Lozovaya et al., 2009) ].
Involvement of cannabinoid-receptors in the negative inotropic actions of cannabinoids has been investigated in several earlier studies [for a recent review, (Batkai and Pacher, 2009) ]. However, the results of these investigations have not been conclusive [for reviews, (Randall et al., 2004; Mendizabal and Adler-Graschinsky, 2007; Malinowska et al., 2012) ]. Both cannabinoid receptor dependent and independent mechanisms have been suggested (Malinowska et al., 2012) . Experiments with AEA and the synthetic cannabinoid HU-210 performed in isolated Langendorff rat hearts and in isolated, electrically stimulated human atrial appendages (Ford et al., 2002; Bonz et al., 2003) have revealed a negative inotropic effect of cannabinoids that may underlie the ability of AEA and HU-210 to decrease cardiac output as observed in studies performed in vivo (Wagner et al., 2001) . In a recent study, it was found that a synthetic cannabinoid A-955840 inhibits the function of L-type Ca 2+ channels in rabbit heart in a manner not sensitive to CB1 and CB2 antagonists (Su et al., 2011) . On the other hand, in another recent study, AEA was reported to inhibit L-type Ca 2+ channels by the activation of CB1 receptors (Li et al., 2009) . In this study, AEA in the concentration range of 10 nM to 1 µM
potently inhibited the function of Ca 2+ channels and the effect of AEA was reversed by CB1 receptor antagonists. In our experiments, AEA was not effective at concentration lower than 1 µM. In addition, in our study, the inhibitory effect of AEA was not reversed by the antagonists of CB1 and CB2 receptors. Differences between two studies could be due to different strains of rats used (SpragueDawley in their study versus Wistar rats in the present study). Our findings suggest that neither CB1
nor CB2 receptors are involved in AEA inhibition of L-type Ca 2+ channels in rat cardiomyocytes.
Although PTX-sensitive signal transduction is well documented for cannabinoid agonists, cannabinoid coupling to PTX-insensitive G q has been reported in several studies (McIntosh et al., 2007; Straiker et al., 2002; Ishii and Chun, 2002) . Therefore, the effect of AEA through PTX-insensitive pathway cannot be excluded.
AEA belongs to a group of fatty acid-based molecules called long-chain N-acylethanolamines (NAEs) which are produced abundantly in response to tissue necrosis and cellular stress (Hansen et al., 2000; Berger et al., 2004) . In fact, accumulation of NAEs was first observed in experimental myocardial infarction induced by ligation of coronary arteries in canine heart [(Epps et al., 1979; Epps et al., 1982) for a review, (Schmid and Berdyshev, 2002) ]. It was demonstrated that NAE content increases up to 500 nmol/g (approximately 500 μM) in infarcted areas of canine heart during ischemia (Epps et al., 1979) . Although AEA constitutes minor (1-3 %) portion of total NAE levels (Schmid and Berdyshev, 2002) , the results of this study may have important implications regarding the contractile responses of ventricular myocytes to ischemia and cellular stress (Hansen et al., 2000; Schmid and Berdyshev, 2002; Berger et al., 2004) . We have previously reported that major NAEs species including AEA produced during ischemia have significant effects on the amplitudes and kinetics of action potentials and accompanying ionic currents that could account for the negative ionotropic actions of these compounds on ventricular myocytes (Voitychuk et al., 2012) . For example, functions of voltage-gated Ca 2+ (Oz et Accepted Article al., 2000) ; (Oz et al., 2004; Oz et al., 2005; Alptekin et al., 2010; Voitychuk et al., 2012) and Na + (Voitychuk et al., 2012; Gulaya et al., 1993) channels have been demonstrated to be modulated by NAEs. In the concentration range used in our study, AEA has been shown to inhibit the function of various cardiac ion channels in cannabinoid receptor-independent manner. For example, AEA blocks T-type Ca 2+ channels (Cav3.1 and Cav 3.2) (Chemin et al., 2007) and cardiac Kv1.5 (Barana et al., 2010) and Kv4.3 in a receptor-independent manner. These effects may contribute to the overall effects of AEA on action potential and myocyte function.
In conclusion, the results indicate for the first time that AEA interacts directly with Na + and Ltype Ca 2+ channels in ventricular myocytes in a manner that is independent of CB1 and CB2 receptors. 
